Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-02 @ 2:17 AM
Study NCT ID:
NCT00908232
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2009-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
Sponsor:
Janssen-Cilag International NV
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-21
First Submit QC Date:
None
Study First Post Date:
2009-05-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-04
Results First Submit QC Date:
None
Results First Post Date:
2012-06-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-14
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED